Aurobindo Pharma shares fell following the news that the US Food and Drug Administration has issued the Establishment Inspection Report (EIR) for the new injectable facility of Eugia Steriles
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
